Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
ID: 355172Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355172

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-243.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)." This initiative aims to encourage community-engaged research that enhances the understanding of children's language development and the factors influencing it, particularly through the development of innovative, culturally and linguistically responsive measurement tools. The funding opportunity emphasizes inclusivity and aims to address disparities in language development among underrepresented populations, requiring applicants to submit a Community Engagement Plan and a Plan for Enhancing Diverse Perspectives. Applications will be accepted starting September 5, 2024, with a submission deadline of October 5, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at NIH Grants.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-243-Full-Announcement.html
    PAR-24-243.html
    The Department of Health and Human Services is offering a funding opportunity focused on advancing research in language development for children through community-engaged research. Specifically, the Eunice Kennedy Shriver National Institute of Child Health and Human Development and other participating organizations aim to develop innovative, culturally and linguistically responsive measurement tools. The goal is to better understand children’s language development and identify effective intervention strategies, particularly for populations frequently underrepresented in research. Applications must include a Community Engagement (CE) Plan and a Plan for Enhancing Diverse Perspectives (PEDP), which are critical for the project's scientific and technical evaluation. The funding opportunity (FON: PAR-24-243) allows for new applications with budgets reflecting actual project needs, and the maximum project period is five years. Notably, this initiative excludes clinical trial proposals and emphasizes rigorous, transparent research practices. Important dates include the opening of applications on September 5, 2024, with a submission deadline on October 5, 2024. This funding opportunity reflects the NIH's commitment to fostering inclusivity and relevance in research that addresses disparities in language development for children across various backgrounds.
    Similar Opportunities
    Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancement and Innovation in Measurement of Language Development and Predictors," aimed at fostering community-engaged research that enhances the understanding of children's language development through culturally and linguistically responsive measures. Applicants are required to develop a Plan for Enhancing Diverse Perspectives (PEDP) and a Community Engagement (CE) plan, focusing on innovative tool development for assessing language capabilities across diverse populations and communicative contexts. The total funding available for projects is capped at $275,000 over a two-year period, with applications due by September 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-244.html.
    Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the R21 Exploratory/Developmental Research Grant under the initiative titled "Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children." This funding opportunity aims to support research that utilizes existing data to explore the developmental patterns of children identified as late talkers, potentially influenced by factors such as premature birth or trauma, while promoting the creation and sharing of open data resources to identify predictors of developmental outcomes. The initiative is significant in addressing gaps in understanding early language development and aligns with NIH's goals of modernizing biomedical research and enhancing data accessibility. Applications are due by January 7, 2024, with a maximum funding amount of $275,000 available over a two-year period. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the R21 Exploratory/Developmental Research Grant to support research focused on the information and practice needs of caregivers, professionals, and stakeholders involved with late talking children. This initiative, part of the Tackling Acquisition of Language in Kids (TALK) program, aims to identify gaps in knowledge and effective support strategies for this population through community-engaged and qualitative research methods. The total budget for each project may not exceed $275,000 over a two-year period, with applications due by 5 PM local time on November 19, 2024. Interested applicants can find more information and submit inquiries via email to grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-046.html.
    NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity for low-risk clinical trials in communication disorders under Funding Opportunity Number PAR-24-051. This initiative aims to support investigator-initiated projects that develop effective interventions in areas such as hearing, speech, and language, specifically targeting low-risk clinical trials that do not require FDA oversight and adhere to budget limits of under $500,000 in direct costs per year. The funding is particularly significant for enhancing research in communication disorders, ultimately improving public health outcomes through scientifically validated interventions. Interested applicants can submit proposals starting January 5, 2024, with the opportunity closing on January 8, 2028; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)" aimed at expanding knowledge of disorders that are currently or may become part of statewide newborn screening programs. This initiative seeks to gather comprehensive data on the natural history of these conditions to facilitate appropriate interventions for affected infants, improve diagnostic accuracy, and support the development of targeted treatments. The funding will assist in identifying biological mechanisms, understanding genetic diversity, and establishing data collection systems for longitudinal studies, emphasizing the importance of research in newborn screening. Interested applicants, including various educational and community organizations, can submit proposals with a maximum project period of five years, with the funding cycle opening on January 5, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-227.html.
    NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)" aimed at supporting independent research projects that enhance workforce diversity in health-related sciences. This initiative specifically targets Early Stage and New Investigators from diverse backgrounds, particularly those underrepresented in biomedical, clinical, and social sciences, and does not require preliminary data for application submissions. The NIH intends to commit $2.7 million to this program, with individual awards capped at $500,000 per year for a maximum duration of five years. Interested applicants can find more information and application details at the NIH grants website, and they must submit their applications by February 6, 2025, with the application submission opening on January 28, 2024.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)." This grant aims to stimulate innovative research addressing critical issues related to communication disorders—such as hearing, balance, taste, smell, voice, speech, and language—specifically for individuals living with HIV/AIDS. The initiative encourages multidisciplinary collaborations and supports low-risk clinical trials that do not require FDA oversight, with a total funding limit of $275,000 for two-year projects, and no more than $200,000 in any single year. Interested applicants, including various academic institutions and nonprofits, must submit their proposals by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering a funding opportunity titled "NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)." This initiative aims to support cooperative agreements for clinical trials that require FDA oversight, are intended to establish efficacy, or present higher risks to participants, with a budget exceeding $700,000. The funding is crucial for advancing clinical practices in treating communication disorders, emphasizing the inclusion of diverse populations in recruitment and retention strategies. Interested applicants, including various educational and nonprofit organizations, must submit their applications by January 27, 2024, and can find more information at NIH Grants.
    New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "New Approaches for Measuring Brain Changes Across Longer Timespans" (Funding Opportunity Number PAR-24-160). This initiative aims to encourage multidisciplinary research that innovatively measures brain activity, connectivity, and other aspects of neurodevelopment across various age groups, with a focus on longitudinal studies that can include both human and animal subjects. The opportunity is significant for advancing methodologies in brain research, particularly in understanding cognitive health and diseases over the lifespan. Interested applicants must submit their proposals by May 5, 2024, and include a Plan for Enhancing Diverse Perspectives (PEDP), adhering to rigorous methodological standards. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-160.html.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)" aimed at stimulating research related to communication disorders associated with HIV/AIDS. This initiative encourages innovative, hypothesis-driven research that addresses high-priority areas such as hearing, speech, and language, with a focus on low-risk clinical trials that do not require FDA oversight. Eligible applicants include a wide range of organizations, such as higher education institutions and community-based organizations, with funding available up to $499,999 per year for projects lasting up to five years. Interested parties should submit their applications by January 7, 2026, and can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the announcement page at https://grants.nih.gov/grants/guide/pa-files/PAR-23-099.html.